Monocyte isolation and DC differentiation were performed as described previously.4 (link) Briefly, monocytes were obtained using the adherence method, where PBMCs were plated in adherent plastic plates (Sarstedt, Nümbrecht, Germany) in medium (X-Vivo 15 medium, Lonza, Basel, Switzerland) supplemented with 5% human serum, 2 mM L-glutamine and 1 mM sodium pyruvate (Thermo Fisher Scientific, Waltham, MA, USA), 1,000 U/mL (100 ng/mL) IL-4, and 800 U/mL (50 ng/mL) Granulocyte-macrophage colony-stimulating factor (GM-CSF) (both from STEMCELL Technologies) and incubated in a CO2, 37°C incubator for 7 days. On day 4, the medium was replaced with fresh medium supplemented with IL-4 and GM-CSF. On day 7, DCs were matured with maturation medium containing 1,000 U/mL (100 ng/mL) IL-4, 800 U/mL (50 ng/mL) GM-CSF, 10 ng/mL tumor necrosis factor alpha (TNF-α) (STEMCELL Technologies), 1 μg/mL PGE2 (Sigma), 10 ng/mL IL-1β (Feldan, Quebec City, QC, Canada), and 100 ng/mL IL-6 (Miltenyi Biotec, Bergisch Gladbach, Germany) and loaded with the desired peptide (1 μg/mL LMP2426–434, [CLGGLLTMV] or 1 μg/mL WT137–45 [VLDFAPPGA], both from JPT Peptides (Berlin, Germany). Last, DC medium was supplemented with interferon γ (IFN-γ; 1,000U/mL, Feldan) for the last 24 h of maturation.
Free full text: Click here